Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.51B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$411M |
| 3 |
Microsoft
MSFT
|
+$300M |
| 4 |
Apple
AAPL
|
+$284M |
| 5 |
Visa
V
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$254M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$178M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$177M |
| 4 |
Blackstone
BX
|
+$139M |
| 5 |
Exelon
EXC
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.38% |
| 2 | Technology | 11.34% |
| 3 | Miscellaneous | 10.58% |
| 4 | Energy | 8.74% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
iShares MSCI Mexico ETF
EWW
$1.49B
| $80K | ﹤0.01% |
1,770
-500,000
| -100% | -$22.2M |
2013 Q4
24 quarters
|
|
|
ACH
3602
Accendra Health
ACH
$42.9M
| $80K | ﹤0.01% |
15,561
+1,566
| +11% | +$10.1K |
2013 Q2
26 quarters
|
|
3603
Palomar
PLMR
$3.31B
| $80K | ﹤0.01% |
1,577
+1,061
| +206% | +$49.7K |
2019 Q2
2 quarters
|
|
|
BPTH
3604
DELISTED
Bio-Path Holdings Inc
BPTH
| $80K | ﹤0.01% |
501
+340
| +211% | +$64K |
2017 Q3
9 quarters
|
|
|
CNBKA
3605
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $80K | ﹤0.01% |
887
+96
| +12% | +$8.38K |
2019 Q2
2 quarters
|
|
|
ADVM
3606
DELISTED
Adverum Biotechnologies
ADVM
| $79K | ﹤0.01% |
682
+208
| +44% | +$18.3K |
2019 Q2
2 quarters
|
|
3607
CEVA Inc
CEVA
$1B
| $79K | ﹤0.01% |
2,897
+286
| +11% | +$7.81K |
2014 Q2
22 quarters
|
|
3608
PC Connection
CNXN
$2.34B
| $79K | ﹤0.01% |
1,596
+530
| +50% | +$24.6K |
2015 Q4
16 quarters
|
|
3609
First Trust Financials AlphaDEX Fund
FXO
$1.03B
| $79K | ﹤0.01% |
+2,350
| New | +$76.4K |
2019 Q4
0 quarters
|
|
|
DSKE
3610
DELISTED
Daseke, Inc. Common Stock
DSKE
| $79K | ﹤0.01% |
25,096
+14,068
| +128% | +$41.2K |
2018 Q2
6 quarters
|
|
3611
CALL
Bausch Health
BHC
$2.14B
| $78K | ﹤0.01% |
+2,600
| New | +$67.6K |
2019 Q4
0 quarters
|
|
|
SBOW
3612
DELISTED
SilverBow Resources, Inc.
SBOW
| $78K | ﹤0.01% |
7,877
+6,502
| +473% | +$61.6K |
2017 Q4
8 quarters
|
|
|
I
3613
DELISTED
INTELSAT S. A.
I
| $78K | ﹤0.01% |
11,106
-70,420
| -86% | -$1.11M |
2016 Q3
13 quarters
|
|
3614
Intellia Therapeutics
NTLA
$1.7B
| $77K | ﹤0.01% |
5,258
+1,300
| +33% | +$18.1K |
2016 Q3
13 quarters
|
|
3615
Construction Partners
ROAD
$5.12B
| $77K | ﹤0.01% |
4,535
+1,118
| +33% | +$19.6K |
2019 Q2
2 quarters
|
|
|
SHYF
3616
DELISTED
The Shyft Group
SHYF
| $77K | ﹤0.01% |
4,242
+1,232
| +41% | +$20.6K |
2017 Q3
9 quarters
|
|
|
SJT
3617
San Juan Basin Royalty Trust
SJT
$176M
| $77K | ﹤0.01% |
30,400
| – | – |
2013 Q2
26 quarters
|
|
|
TDF
3618
Templeton Dragon Fund
TDF
$241M
| $77K | ﹤0.01% |
3,950
| – | – |
2013 Q2
26 quarters
|
|
|
UXIN
3619
Uxin Ltd
UXIN
$301M
| $77K | ﹤0.01% |
339
+118
| +53% | +$31.9K |
2019 Q3
1 quarter
|
|
|
TARO
3620
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $77K | ﹤0.01% |
877
| – | – |
2015 Q3
17 quarters
|
|
3621
Aqua Metals
AQMS
$8.52M
| $76K | ﹤0.01% |
500
-250
| -33% | -$65.1K |
2019 Q2
2 quarters
|
|
3622
Invesco MSCI Sustainable Future ETF
ERTH
$122M
| $76K | ﹤0.01% |
1,516
+376
| +33% | +$17.6K |
2017 Q1
11 quarters
|
|
3623
Marker Therapeutics
MRKR
$17.5M
| $76K | ﹤0.01% |
2,625
-2,041
| -44% | -$74.3K |
2019 Q2
2 quarters
|
|
3624
Phibro Animal Health
PAHC
$1.46B
| $76K | ﹤0.01% |
3,044
+1,002
| +49% | +$23.3K |
2014 Q3
21 quarters
|
|
|
STR
3625
DELISTED
Sitio Royalties
STR
| $76K | ﹤0.01% |
2,693
+1,848
| +219% | +$47.1K |
2019 Q2
2 quarters
|
|
Similar funds
Bank of Montreal's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of Montreal held 5,174 positions worth $133B, up 15% from $116B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of Montreal deployed $8.58B of net new capital in Q4 2019, opening 425 new positions and adding to 2,835 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 28% a quarter earlier, followed by Technology and Miscellaneous.
On the sell side, the largest reduction was Apollo Global Management, an estimated $254M trimmed.
- Bank of Montreal's largest Q4 2019 buy was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.51B increase.
- Bank of Montreal's biggest Q4 2019 reduction was Apollo Global Management, cutting an estimated $254M.
- Bank of Montreal fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $125M.
- Bank of Montreal's ten largest holdings make up 20% of its $133B portfolio in Q4 2019.
- Bank of Montreal opened 425 new positions and closed 298 in Q4 2019.
- Bank of Montreal's portfolio value rose 15% quarter-over-quarter to $133B.
Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.